Status: current, Defined. Date: 31-Oct 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5144488017 | Trabectedin 250 microgram powder for solution for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
5144489013 | Product containing precisely trabectedin 250 microgram/1 vial powder for conventional release solution for infusion (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Trabectedin 250 microgram powder for solution for injection vial | Is a | Trabectedin only product in parenteral dose form | true | Inferred relationship | Some | ||
Trabectedin 250 microgram powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
Trabectedin 250 microgram powder for solution for injection vial | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
Trabectedin 250 microgram powder for solution for injection vial | Has precise active ingredient | Trabectedin | true | Inferred relationship | Some | 1 | |
Trabectedin 250 microgram powder for solution for injection vial | Has BoSS | Trabectedin | true | Inferred relationship | Some | 1 | |
Trabectedin 250 microgram powder for solution for injection vial | Has presentation strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Trabectedin 250 microgram powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 | |
Trabectedin 250 microgram powder for solution for injection vial | Has manufactured dose form | Powder for solution for infusion | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets